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ABSTRACT
Objective: To develop a procedure and tool for medication reconciliation and review of geriatric patients’ 
medications on hospital admission. 
Methods: Action research, with literature review, and physicians, nurses and clinical pharmacists as experts, 
was used in the collaborative development process that first identified problems in the current admission 
process and then developed a procedure and tool in a medium-sized secondary care hospital. The use of the 
procedure and the tool was piloted; the final versions were developed based on the outcomes of the pilot. 
Results: Several problems were identified in the admission medication process, including patients not hav-
ing an up-to-date home medication list and problems with polypharmacy. To solve these problems, the ex-
perts recommended that clinical pharmacists should reconcile and review patients’ medications. A medica-
tion reconciliation and review procedure and tool were developed and piloted. The final tool comprised the 
following sections: Patient Background, Patient Interview, Reconciled Medication and Medication Review, 
and Cautions with Medication. As part of the implementation, a new page was created for the pharmacists' 
medication reconciliation and review notes in the electronic medical record. The study emphasized the cen-
tral role of the clinical pharmacist in the healthcare team. 
Conclusions: The role of a clinical pharmacist in the multidisciplinary healthcare team should be increased 
to promote medication safety. The study introduces a novel tool and procedure for medication reconcilia-
tion and review that has been developed and piloted with a multidisciplinary healthcare team. The tool and 
the clinical pharmacist-led procedure were found feasible to use and central to the rational use of medicines.
Key words: Medication reconciliation, medication review, hospital admission, geriatric patients,  
clinical pharmacist, medication safety
©  DOSIS      1/2019 ©  Suomen Farmasialiitto ry22 ©  Suomen Farmasialiitto ry ©  DOSIS      1/201923
INTRODUCTION
Medication discrepancies, defined as unexplained 
differences between documented regimens across 
different sites of care may give rise to adverse drug 
events (ADEs) (Pippins et al. 2008). Unintentional 
medication discrepancies are often due to errors in 
taking a medication history or not reconciling a list 
of medications. Medication reconciliation at differ-
ent stages of health care has been recognised to re-
duce ADEs and discrepancy rates (National Prescrib-
ing Centre NPC 2008, Meguerditchian 2013). Some-
times viewed as time consuming (Meguerditchian 
2013), medication reconciliation also helps to iden-
tify medication errors between transitions of care, 
thus, preventing ADEs from occurring (Haig 2006, 
Pippins et al. 2008, Meguerditchian 2013, Institute 
for Safe Medication Practices ISMP 2017). Other ben-
efits of medication reconciliation have been shown 
to be, for example, the potential avoidance of medi-
cines-related admissions to hospital, improved mul-
tidisciplinary team-working and greater patient in-
volvement in their own care (National Prescribing 
Centre NPC 2008). 
Admission to, and discharge from, hospital are 
shown to produce a large number of discrepancies in 
patients` drug therapy (Climente-Martí 2010). Thus, 
medication reconciliation should occur at these 
points of transfer, or, ideally throughout a patient´s 
hospital stay (Knez et al. 2011). This is important es-
pecially for geriatric patients. If a list of medications 
is not correct at hospital admission, such problems 
can carry over to the discharge medication (Karap-
inar-Carkit et al. 2010) and cause medication errors 
and harm to the patient on other wards or even af-
ter discharge. 
Especially in the treatment of older patients, it is 
not enough to reconcile the list of home medicines 
without questioning their appropriateness (Quélen-
nec 2013). It is important also to review whether all 
the medicines are clinically appropriate to be con-
tinued at admission, during the hospital stay and at 
discharge. The aim of the study was to develop a tool 
and a procedure for medication reconciliation and 
medication review of older patients at admission to 
a primary care geriatric ward. 
METHODS   
Context of the study
The study was conducted in the city of Lahti located 
near to the capital area in Finland between Febru-
ary 2011 and May 2013. In 2017, the city had a popu-
lation of 119 000 of whom 24 % are aged ≥ 65 years 
(Tietoa Lahdesta 2017). The study site was Lahti City 
Hospital, providing secondary care services to older 
patients. The participating wards were an acute sec-
ondary care ward with 40 beds and an acute reha-
bilitation primary care ward with 30 beds. In early 
2017, the Lahti City Hospital was incorporated into 
the Päijät-Häme Joint Authority for Health and Well-
being integrating primary and secondary care fur-
ther. The permission for conducting this study was 
obtained from Lahti Social and health services. At the 
time of the study, no ethics approval was required 
as this study was regarded as a service development.
Study design, participants and methods
An action research based method comprising six 
stages (Table 1, Figure 1) was utilised (Baum 2006). 
The study process consisted of research, action and 
participation, typical to action research. The aim was 
to achieve a standardised medication reconciliation 
and review procedure. Consequently, a multiprofes-
sional research team of researchers (n=2), academic 
supervisors (n=2), chief physicians (n=2), and clinical 
pharmacists (n=2) of the hospital were involved in 
the development of the tool and the procedure. The 
study and its stages are described briefly in Table 1 
and Figure 1. 
Stages of the study
Stage 1: Literature search for, and narrative review 
of, medication reconciliation and review proce-
dures applicable to admissions to geriatric wards
The aim of the literature search and review was to 
gather national and international guidelines for, and 
examples of, existing tools and procedures for medi-
cation reconciliation and review. This was to support 
the development of the first version of the tool and 
procedure for the Lahti City Hospital. After having 
searched for actual guidelines, tools and procedures, 
the literature search was extended to include articles 
from peer-reviewed journals. The following search 
terms were used for data screening independently 
and as a combination: “medication reconciliation”, 
“medication review” and “admission”. 
Stage 2: Interviews with physicians, nurses and 
clinical pharmacists
Following the literature search and review, several 
interviews were conducted with healthcare staff of 
Lahti City Hospital. Two physicians, three nurses and 
two clinical pharmacists were purposively selected to 
be interviewed individually as expert informants due 
to their experience in patient admission to geriatric 
wards as in Smith (2010). 
A semi-structured interview guide was developed 
based on a) the literature found in Stage 1 and b) sev-
eral discussions with the research team consisting of 
academic and practising experts in medication safe-
ty (Ritchie et al. 2003, Smith 2010). In the individual 
interviews, the informants were invited to describe 
their previous experiences of, opinions on, expecta-
tions for, challenges with, and solutions for, the med-
ication reconciliation and review on admission. The 
interviewees were also asked to describe how clini-
cal pharmacists could contribute to the medication 
reconciliation and review process on admission. The 
interviews were conducted by two researchers (LHR 
and AN). The interviews were audio-recorded and 
transcribed verbatim. Qualitative framework analysis 
was employed in the analysis of all interviews (Ritchie 
et al. 2003, Smith 2010). 
Stage 3: Developing a tool and procedure for 
medication reconciliation and review 
Based on the literature search and review (Stage 1) 
and the interviews (Stage 2), the researchers (AN and 
LHR) developed the first versions of the procedure 
and the tool for medication reconciliation and re-
view for the participating hospital wards. Detailed 
instructions were developed for the procedure to en-
sure that different healthcare professionals, such as 
pharmacists and nurses, would operate in a stand-
ardised way. The research team further refined the 
procedure and the tool (Appendix 1) before the pilot 
as is usual in action research.
Stage 4: Piloting the medication reconciliation 
and review procedure and the tool 
The medication reconciliation and review proce-
dure was piloted in two parts to ensure the feasibility 
of the use of the tool (Appendix 1). The two clinical 
pharmacists who had participated in the interviews 
in Stage 2 conducted the pilots during patients’ ad-
mission to the two wards. The pharmacists were pro-
vided with detailed instructions for completing the 
medication reconciliation and review to ensure they 
operated in a standardised way. 
Altogether eight patients, whose medication was 
reconciled and reviewed according to the procedure 
under development, were included in the pilots. The 
medication reconciliation and review procedure was 
observed by one of the researchers (AN) on the first 
Figure 1. A simplified description of the study process to develop a tool and procedure for medication 
reconciliation and review of geriatric patients on hospital admission.
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day of both pilots to gather information on how 
pharmacists operated and to ensure the feasibility of 
the tool. The first pilot was conducted in January 2013 
and the second in March 2013. The two clinical phar-
macists also provided their feedback to the research 
team. As is usual in action research, further changes 
to the procedure and the tool were based on the ob-
servations of the researcher and the experiences of 
the clinical pharmacists who piloted the use of the 
medication reconciliation and review procedure and 
the tool and were discussed with the research team. 
Stage 5: Feedback discussions with physicians 
Three physicians who had been working on the 
study wards during the first pilot were purposive-
ly selected to feed back on their perceptions of the 
medication reconciliation procedure and the tool dis-
cussions with one of the researchers (AN). Specific 
open questions were presented to extract informa-
tion about medication reconciliation on admission, 
the role of the clinical pharmacist in medication rec-
onciliation and review procedure and what kind of 
medication-related issues are important on admis-
Table 1. Outline of the stages of the study to develop a tool and procedure for medication reconciliation 
and review of geriatric patients on hospital admission.  
Stages of the study Purpose of the stage Method
No.        Description
1 
2
3
4 
5
6
Literature search and 
review on (inter)national 
medication reconciliation 
and review models.
Assessing current 
medication reconciliation 
and review practices 
and needs for their 
development on 
admission to the geriatric 
ward.
Developing a tool and 
procedure for medication 
reconciliation and review.
Piloting the medication 
reconciliation and review 
procedure and the tool.
Feedback discussions 
with physicians.
The development of the 
final version of the tool 
and the procedure.
To identify (inter)national 
models and experiences 
on the topic to inform 
the development and 
implementation of the 
tool and procedure for 
medication reconciliation 
and review.
To identify possible 
problems in the current 
medication process 
on admission to the 
geriatric ward; potential 
improvements that 
interviewees could 
suggest to solve those 
problems.
To develop a preliminary 
medication reconciliation 
and review procedure 
and tool
To explore how the tool 
and the instructions for 
the procedure worked in 
practice.
To explore the opinions 
of the doctors working on 
the ward during the first 
pilot on the functionality 
of the tool and the 
procedure.
To use the feedback 
obtained from the two 
pilots and to get approval 
from researchers and 
practical team for the final 
tool and procedure.
Literature search and 
narrative review
Interviews of informants 
(physicians (n= 2), 
nurses (n=3) and 
clinical pharmacists 
(n=2)) involved in the 
development and piloting 
of the tool in a geriatric 
ward of the study hospital; 
qualitative framework 
analysis of the interviews.
Research team 
discussions, utilising the 
literature review and 
interviews with informants.
Observations and 
feedback from the ward 
pharmacists:
Clinical pharmacists 
(n=2) completed four 
reconciliations and 
reviews. The use of the 
tool was observed by the 
student researcher. 
Feedback discussion with 
the student researcher 
and physicians (n=3).
Feedback discussion with 
researchers (n=2), clinical 
pharmacists (n=2) and the 
geriatrician.
Table 2. International medication reconciliation models adapted from the literature.
Source of the model
Joint Commission (JC) 2013
Institute for Healthcare 
Improvement (IHI) 2013
National Patient Safety 
Agency (NPSA) 2007
National Prescribing Centre 
(NPC) 2013
World Health Organization 
(WHO) 2007
Country
USA
USA
UK
UK
International
Main contents *
The following steps should be covered in the reconciliation 
process: obtaining information on the current medications, 
identifying and resolving discrepancies, providing written 
information on the medications at the time of patient 
discharge from the hospital
The medication reconciliation process should include three 
steps: medication verification (collection of medication 
history), medication clarification (ensuring that  medications 
and doses are appropriate), medication reconciliation 
(documentation of changes in the orders)
Medication reconciliation should be done to all adult 
patients admitting to hospital. Pharmacist should be 
involved in medication reconciliation as soon as possible 
after admission.
NPC suggests prioritizing medication reconciliation to 
certain patients groups; those with long-term conditions, 
those aged 65 years and over, those on four or more 
medicines or on complex dosing regimens.  The 
process comprises the “3Cs” - collecting, checking and 
communicating on the medications. 
Reconciling medication should happen within 24 hours of 
admission. The process should be multidisciplinary and 
involve patients and their careers. Points of transition that 
require special attention are:
• Admission to hospital
• Transfer from the emergency department to other care 
areas (wards, intensive care, or home)
• Transfer from the intensive care unit to the ward
• From the hospital to home, residential aged care facilities 
or to another hospital.
* The key contents in the Table are selected from the presented medication reconciliation models in relation 
to the focus of the present study.
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sion. The physicians were also asked whether they 
would prefer to receive the medication reconcilia-
tion and review recommendations electronically or 
by paper from the clinical pharmacists. 
Stage 6: Feedback discussion with clinical phar-
macists and development of the final medication 
reconciliation and review procedure and the tool
After the second pilot the research team and the 
two clinical pharmacists held a feedback discussion 
as described in Ritchie et al. (2003) and Smith (2010). 
In the discussion, the researchers received feedback 
on the feasibility and usability of the procedure and 
the tool. The final versions of the tool (Appendix 1) 
and the procedure (Appendix 2) were developed by 
the research group based on the feedback discussions 
at stages 5 and 6.
RESULTS
Literature review
The international medication reconciliation models 
and guidelines relevant to the development of the 
medication reconciliation and review process in this 
study are presented in Table 2. 
Interviews with physicians, nurses and clinical 
pharmacists
The main themes raised in the individual interviews 
of physicians (n=2), nurses (n=3) and clinical pharma-
cists (n=2) were: a) problems in the current medica-
tion process and b) the role of the clinical pharmacist. 
The interviewees recommended that the role of the 
clinical pharmacist should be significantly increased 
in the hospital admission process. The tasks should 
focus more on medication reconciliation and review, 
and patient care. Other proposals for clinical phar-
macists’ contribution to patient care in the admission 
process were patient interviews about their medica-
tions and possible encountered problems, and iden-
tification of symptoms that might be attributed to 
drug-related problems (DRPs).
The interviewees were concordant regarding the 
problems experienced, such as lack of an up-to-date 
home medication list in the current medication pro-
cess of the hospital wards (Table 3). The healthcare 
professionals interviewed also presented solutions to 
the problems identified with the help of clinical phar-
macists in the medication reconciliation and review 
process. Furthermore, the interviewed physicians and 
nurses expressed a need for the clinical pharmacist to 
be present on the wards more often to contribute to 
patient care with their expertise. This was perceived 
pivotal to improving patient safety and facilitating 
both nurses' and physicians' work. Additionally, one 
of the physicians suggested that clinical pharmacists 
could perform clinical medication reviews focussing 
on the indications of drugs, their potential interac-
tions and inappropriate medications prescribed to old-
er patients (for example suitability of medicines ac-
cording to the age and kidney function of a patient). 
The interviewed clinical pharmacists thought this 
could be helpful in identifying and solving DRPs (Ta-
ble 3). During the first pilot, the clinical pharmacists 
fed back that the procedure was time consuming.
Feedback discussion with physicians  
between the pilots 
Physicians (n=3) participating in the study found 
the medication reconciliation and review procedure 
completed by the clinical pharmacists in the first pi-
lot central to the rational and safe medication use. 
The physicians suggested a concept in which the clin-
ical pharmacist would document their medication 
therapy related notes and recommendations into the 
electronic medical record. In this way, also other phy-
sicians working at the hospital and other health care 
providers in outpatient care could later access the 
notes and recommendations. One of the physicians 
suggested that a specific page in the electronic pa-
tient records should be created for the notes for the 
medication reconciliation and review; this was im-
plemented. The physicians emphasised that the clini-
cal pharmacists should not only document but also 
discuss any identified DRPs and recommendations 
to solve them with the physician in charge of any 
patient’s treatment. They also suggested that phar-
macists should prioritise the recommendations for 
medication changes for each patient. 
Development of the final version of the tool and 
procedure through the feedback discussion with 
the clinical pharmacists
The interviewees (n=7) found the medication rec-
onciliation and review procedure to be very useful 
in solving DRPs among older patients on admission. 
The clinical pharmacists agreed with the physicians` 
opinion suggesting that a specific page should be cre-
ated for the medication reconciliation and review in 
the electronic medical record to promote informa-
tion transfer. This would support the medication rec-
onciliation and review in a structured way so that 
the physician could easily see which DRPs are to be 
addressed. 
Consequently, the final versions of the tool and 
procedure were developed based on the findings of 
all the previous stages of the study. The final version 
of the tool (Appendix 1) comprised four main sec-
tions (1) Patient Background (e.g. reason for admis-
sion and laboratory data), (2) Patient Interview (e.g. 
experiences of symptoms from, and problems with, 
medicines), (3) Medication Reconciliation and Review 
(i.e. identified DRPs), and (4) Recommendations (i.e. 
actions to solve DRPs). The final medication recon-
ciliation and review procedure recommends that all 
parts of the process are completed by a clinical phar-
macist who provides recommendations for any med-
ication related changes required to the physicians. 
DISCUSSION
Our study introduces a tool and a procedure for med-
ication reconciliation and medication review of older 
patients’ medications on admission to the geriatric 
ward of a secondary care hospital. This study also 
presents a practical action research based method 
for developing and implementing clinical pharma-
cy services through multidisciplinary collaboration 
in clinical environments where such approaches to 
medication care are novel. The literature describes, 
similarly, multidisciplinary teams, involving pharma-
cists, using sophisticated models of medication opti-
mization in countries pioneering in clinical pharma-
cy (Gillespie et al. 2009, Hellstrom et al. 2012, Kaboli 
& Fernandes 2012). 
The practitioners and nurses interviewed in the 
study expressed an urgent need for clinical pharma-
cists as operators in medication reconciliation and 
review to assure safe and rational use of medications. 
Special value was attributed to the clinical pharma-
cists in their contribution to addressing the suita-
bility of medicines according to the age and renal 
function of a patient, suitable dosages and forms of 
medication and identification of clinically relevant 
interactions. Indeed, many studies have recognized 
Table 3. Perceived problems in the current medication process and suggested improvements based on 
the interviews of physicians (n=2), nurses (n=3) and clinical pharmacists (n=2) at first stage of the study.
Perceived problems in the current 
medication process
Patients do not remember which medicines 
they are taking
Patients do not have an up-to-date home 
medication list with them on admission
Patient medical records are not accurate, 
up to date, or have discrepancies between 
different care settings (e.g. care homes, 
primary and secondary care, and private 
and public healthcare providers)
Polypharmacy (increased risk of  therapeutic 
duplication, interactions, prescribing without 
indication or inappropriate therapy)
Incorrect medication, incorrect dose, route, 
or frequency  especially in aged patients
Differentiating between co-morbidities and 
adverse side effects
Suggested improvements to the 
medication process
A clinical pharmacist could interview the patient, 
family members, physicians and other healthcare 
professionals and check patient records.
A clinical pharmacist could interview the patient, 
family members, physicians and other healthcare 
professionals and check patient records.
A clinical pharmacist could reconcile the 
medication on hospital admission.
A clinical pharmacist could clinically review the 
medication.
A clinical pharmacist could clinically review the 
medication.
A clinical pharmacist could have an important role 
on identifying whether the patient is suffering due 
to illness or having an adverse side effect, even 
the rare adverse effects could be noticed.
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the important role of a clinical pharmacist in these 
processes of care (Beckett 2012, Aag 2014, Leguelinel-
Blache 2014). Moreover, it is reported that clinical 
pharmacists collect more complete and accurate in-
formation on patients’ medications when compared 
to nurses and physicians due to the consultation of 
more information sources in medication reconcilia-
tion processes (Lizer & Brackbill 2007, Steurbaut et 
al. 2010).
Our study is timely as the number of older patients 
needing primary care level hospital care with special 
expertise in geriatrics is increasing in Finland as well 
as in all over the world. Geriatric patients in particu-
lar have usually many DRPs and, therefore, there is 
a specific need to ensure that medications are rec-
onciled and reviewed during their stay in hospital 
(Knez et al. 2011, Spinewine et al. 2012, Bulajeva et al. 
2014). It is reported that the geriatric patients ben-
efit most from medication reconciliation and medi-
cation reviews (Gillespie et al. 2009, Steurbaut et al. 
2010, Mueller et al. 2012). Indeed, the medication rec-
onciliation and review procedures were combined 
to ensure that up-to-date information of patients’ 
medications and possible discrepancies are brought 
to the attention of the physician during the hospi-
tal admission. This represents a more thorough ap-
proach to medication optimization and ensuring 
medication safety while many hospitals have limit-
ed the process to medication reconciliation (Nester 
2002, Gleason 2004, Beckett 2012). The admission 
phase of the medication process has been identified 
as especially prone to medication errors due to in-
sufficient information about the patients’ previous 
medications (Tam et al. 2005, Steurbaut 2010). This 
emphasizes the importance of the identification of 
patients’ up-to-date medication lists. Equally impor-
tant would be to cover possible inappropriate medi-
cations, interactions or other DRPs in the current 
medication to avoid further discrepancies with the 
newly prescribed medications during the hospital 
stay (Karapinar-Carkit et al. 2010). Moreover, DRPs 
are a common reason for hospital admissions, espe-
cially in geriatric patients (Gillespie et al. 2009, Som-
ers 2010, Chau et al. 2016). 
The participating physicians called for clearer 
and more accessible documentation of medica-
tion related problems identified by the pharmacist 
on hospital admission. The physicians suggested 
that there should be a clearly identified place in the 
electronic medical records for a ward pharmacist to 
document their notes and recommendations in a 
standardised way. This has been identified as a cen-
tral success factor of a well-functioning medication 
reconciliation and review procedure also in other 
studies (Gillespie et al. 2009, Steurbaut et al. 2010, 
Meguerditchian 2013, Leguelinel-Blache 2014). In-
deed, medication reconciliation and review on ad-
mission improves the quality and safety of medi-
cine use throughout a patient`s hospital stay until 
discharge (Knez et al. 2011). Electronic medical re-
cords shared between primary and secondary care 
enable also primary care physicians to read notes 
written by clinical pharmacists. Thus, the proce-
dure can also benefit the quality and safety of medi-
cation use of the home-dwelling aged – a health-
care domain that would urgently need adoption of 
clinical pharmacy services in many countries (Chau 
et al. 2016). 
Strengths and limitations 
While the study was conducted on two geriatric 
wards, providing secondary and primary care servic-
es, in a Finnish middle-sized hospital, the laws and 
regulations governing healthcare are universally val-
id, and, thus, the admission processes and practices 
might not vary too much across different settings in 
Finland. Indeed, the medication reconciliation and 
review procedure and the tool could be transferable 
to other healthcare settings in Finland and to other 
countries as the development of the procedure and 
the tool was based on international models (Table 2). 
Thus, with some additional local adaptation, the tool 
could also be useful for medication reconciliation 
and review of geriatric patients in all types of wards 
and settings. With the number of geriatric patients 
steadily increasing in Finland and many other coun-
tries, the need for the use of expertise of clinical phar-
macists, and the developed procedure and the tool, 
in patient care increases. 
The tool was piloted independently by two clinical 
pharmacists on a secondary and primary care ward, 
representing the possibility for different ways of rec-
onciling and reviewing medications, and hence, in-
fluencing the findings of the study. Indeed, the differ-
ent experiences and perspectives of the clinical phar-
macists provide rich data (Ritchie et al. 2003) on the 
feasibility of the use of the medication reconciliation 
and review procedure and the tool in practice, en-
hancing the feasibility of their use in other settings. 
On the other hand, no clinically relevant differences 
in the clinical pharmacists` contribution to patient 
care were observed in the pilots, showing the medi-
cation reconciliation and review were completed in 
a standardised way. 
While the experiences of this study might not 
be directly transferable into countries and health-
care systems where pharmacists involved in multi-
disciplinary teams are not an everyday practice, this 
practical action research based method for develop-
ing and implementing clinical pharmacy services 
can also be used in settings where such approach-
es to medication care are novel. Our study success-
fully employed an action research based method fa-
cilitating the development and implementation of 
an innovative medication reconciliation and review 
procedure and tool. The central key benefit of the 
chosen method was its ability to involve and com-
mit local healthcare professionals, physicians, nurs-
es and pharmacists in the development of the pro-
cedure and the tool and in the change of their own 
and their co-workers’ practices. 
Recommendations
The present work and previous studies have 
found medication reconciliation time consuming 
(Meguerditchian 2013). Thus, standardisation of the 
medication reconciliation process and more well-or-
ganised use of health information tools could im-
prove the efficiency of the process. While our medi-
cation reconciliation and review procedure might be 
too comprehensive and time consuming (this was the 
start of the service) for use at admission of every aged 
patient, the alternative courses of action would be to 
develop a shorter procedure with a simple check-list 
outlining the most central items to be covered on 
admission for all geriatric patients and target a more 
limited group of geriatric patients, for example, based 
on screening of DRP-related admissions (Gillespie et 
al. 2009, Dimitrow et al. 2014), when using the cur-
rent procedure. Consequently, there is a need for fur-
ther research to identify which patients benefit the 
most from the current medication reconciliation and 
review procedure on admission. 
There is also a need to promote the use of clini-
cal pharmacists and their competence in patient care 
teams. While the number of clinical pharmacists is 
on the increase in Finnish hospitals (Schepel 2018), 
the numbers might not be sufficient for every patient 
to benefit from clinical pharmacist-led medication 
reconciliation and review. In the future, medication 
reconciliations and medication reviews should be 
documented electronically to facilitate sharing and 
transferring the most accurate information on pa-
tients’ medications between different healthcare pro-
fessionals and settings, and patients and their carers. 
Conclusions
The study introduces a novel tool and procedure for 
medication reconciliation and review on hospital 
admission of geriatric patients that has been devel-
oped and piloted with a multidisciplinary healthcare 
team, using an action research based method. The 
tool and the clinical pharmacist-led procedure were 
found feasible to use and central to the rational use 
of medicines. While multidisciplinary team work en-
sured the implementation, medication reconciliation 
and reviews were recommended to be completed by 
clinical pharmacists who provide their medication-
related recommendations to the physicians.
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*Kirjeenvaihto
Tavoite: Tutkimuksen tavoitteena oli kehittää työkalu 
ja toimintamalli lääkityksen arviointiin iäkkään poti-
laan tullessa perusterveydenhuollon osastolle. 
Aineisto ja menetelmät: Työkalun ja toimintamallin 
kehittämisessä käytettiin toimintatutkimusmenetel-
mää. Tutkimus tehtiin keskikokoisessa terveyskes-
kussairaalassa. Kehitysprosessiin osallistui yhteis-
työssä lääkäreitä, hoitajia ja osastofarmaseutteja 
(n=7). He tunnistivat ongelmia nykyisessä osastolle 
tulon yhteydessä tehtävässä lääkityksen arvioinnissa 
ja kehittivät alustavan työkalun, josta pilotoinnin avul-
la kehitettiin lopullinen versio. 
Tulokset: Useita ongelmia havaittiin lääkitysproses-
sissa iäkkään potilaan saapuessa osastolle. Potilaalla 
ei useinkaan ollut ajan tasalla olevaa kotilääkitys-
listaa mukanaan, tai eri tietolähteissä oli toisistaan 
poikkeavia lääkitystietoja. Useilla potilailla oli moni-
lääkitykseen liittyviä ongelmia. Kehitysprosessiin 
osallistuneet asiantuntijat ehdottivat näiden ongelmi-
en ratkaisemiseksi osastofarmaseuttien ajantasaista-
van ja arvioivan lääkityksiä aikaisempaa useammin. 
Heidän myös toivottiin haastattelevan potilaita osana 
osastolle tuloarviointia. Toimintamallin kehittämisen 
yhteydessä kehitettiin potilastietojärjestelmään erilli-
nen sivu farmaseutin lääkitysarviomerkintöjä varten. 
Lopullinen työkalu sisältää seuraavat osiot: potilaan 
taustatiedot, potilaan haastattelu, ajantasaistettu 
ja arvioitu lääkitys, lääkitykseen liittyvät huomiot ja 
ehdotukset.
Johtopäätökset: Osastofarmaseutin roolia pitäisi 
lisätä iäkkäiden potilaiden sairaalaan tulovaihees-
sa lääkitysturvallisuuden lisäämiseksi. Tässä tutki-
muksessa kehitettiin ja pilotoitiin moniammatillise-
na yhteistyönä työkalu ja toimintamalli lääkityksen 
tuloarviointiin. Lääkityksen ajantasaistaminen ja lää-
kityksen arviointi ovat tärkeitä ja aikaa vieviä osas-
tofarmaseutin tehtäviä. Lisäkehittämistä tarvitaan, 
jotta kaikki farmaseuttisen henkilökunnan tekemät 
havainnot saadaan sähköisinä ja helposti kaikkien 
potilasta hoitavien henkilöiden saataville.
Avainsanat: Lääkityksen ajantasaistaminen, lääki-
tysarvio, sairaalaan tulovaihe, iäkkäät potilaat, osas-
tofarmasia, lääkitysturvallisuus
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APPENDIX 1. Tool for Medication Reconciliation and Review on Admission for Pharmacists
Date: ________________________    Patient code: ________________________
Starting time for collecting preliminary data: ________________________
    
Time pharmacist used collecting preliminary data: ____ minutes 
Basic patient data:
Year of birth: ________________________     
Gender:  n  Female  n  Male
Date of admission: ________________________
Reason for admission: _________________________________________________________________
Other diagnoses: ____________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
Place where admitting: 
  n  Primary care  n  Home care services  n  Nursing home  n  Long-term institution 
Admitting from central hospital     n   No  n  Yes 
Medicine allergies:   n  No   n  Yes: ________________________________________________
Kidney function:  GFR _____ ml/min     classification ___________
Length: ___________ m BMI: __________ kg/m2
  Blood pressure (sitting)
  Pulse
  Weight
>
result/date result/date result/date comments
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Number of deleted medications ____________ 
Medication reconciliation:  Patient code: ____________ 
PATIENT INTERVIEW:
Starting time of interview: ____________ 
Time pharmacist used interviewing the patient: ____________ min
 
What's the reason you are in hospital? 
__________________________________________________________________________________
What kind of condition have you had at home /in nursing home?
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
Patient is asked to tell which medicines or over-the-counter-medicines she/he is using, when, why and what 
is the dose. Patient is asked if she/he is using any creams, inhalations, nasal sprays, sleeping pills etc. In 
your medication record there is a medicine like this (name of medicine), have you been using it? (The aid is 
medication list in the electronical medication record, which is enclosed to this form. All the notes are made to 
this medication list.)
In which indication do you use this medication? 
__________________________________________________________________________________
Further notes: 
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
With who do you speak about your medicines? From who do you ask about your medicines?  
Have you got advices using your medicines?
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
Laboratory test
P-Krea
P-K
P-Na
P-INR
B-Hb 
E-MCV
P-CRP
B-Trom
P-Alb 
fP-Gluk
B-HbA1c
P-ALAT
P-Bil
P-BNP
P-Uraat
fP-Kol
fP-Kol-HDL
fP-Kol-LDL
fP-Trigly
S-D-25
Ca++
S-B12-Vit
S-TSH
S-T4-V
fE-folaat
S-GT 
result/date result/date result/date Reference value
50-90 μmol/l
3,5–4,4 mmol/l
137–144 mmol/l
varfarin treatment: 2-3,5
f: 117–155 g/l 
m: 134–167 g/l
82-98 fl
<10
150–360 E9/l
40-69 y: 36-45 g/l
over 70 y: 34-45 g/l
3,9-6,4 mmol/l
20–42 mmol/ml
DM: 42–53 mmol/ml
10–45 U/l
4-20 μmol/l
<100
155–400 mmol/l
<5,0 mmol/l
> 1,00 mmol/l
< 3,00 mmol/l
< 2,00 mmol/l
25-175 nmol/l
1,05–1,20 mmol/l
140–490 pmol/l
0,4-4,0 mU/l
9-19 pmol/l
<360 nmol/l
f (> 40 v.): 10-75 U/l
m (> 40 v.): 15-115 U/l
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Do you take care taking your medicines yourself or is someone helping you?  
Do you use any medications aids (for example dispenser)? In which stages do you feel you need help?
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
How have you managed with your medicines? 
What kind of problems you may have had with your medicines?
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
Have you had any symptoms (at home /nursing home) related to your illnesses or any other symptoms?
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
Do you smoke?  n  No   n  Yes: How much? ______________________________________
Do you use alcohol?       n  No      n  Yes: How much? _______________________________
Is there something you would like to talk related to your medicines?
__________________________________________________________________________________
__________________________________________________________________________________
Other notices:
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
The medication reconciled and medication review: 
  
Patient code: ____________   Starting time of medication reconciliation and review: ____________ 
Time pharmacist used in medication reconciliation and review  (does not include tasks to do prior meeting 
the patient or patient interview): ____________ minutes
Nr
1.
2.
3.
4.
5.
6.
7.
Indication
n  Yes
n  No
n  Yes
n  No
n  Yes
n  No
n  Yes
n  No
n  Yes
n  No
n  Yes
n  No
n  Yes
n  No
S/T/K/I Consumption
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
Problem 
(code + description)
>
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Nr
8.
9.
10.
11.
Indication
n  Yes
n  No
n  Yes
n  No
n  Yes
n  No
n  Yes
n  No
S/T/K/I Consumption
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
 
n  In use
n  Paused
n  Should be in use
n  Should not be in use
n  Not knowledge about use 
 
Problem 
(code + description)
>
S = Regularly used medication T = On demand medication K = Cure I = Self care medication
A. unnecessary medication  B. need s additional drug therapy C. medication without effectiveness  
D. incorrect dose, too low E. incorrect dose, too high F. incorrect lenght of therapy G. incorrect frequency  
H. incorrect dosing time  I. adverse effect  J. interaction  K. therapeutic duplication  L. incorrect medicine 
M. problems with compliance N. need for monitoring O. need for  counselling P. another problem, specify 
(choose all the suitable alternatives)
Cautions with medication:
Patient code: ____________   
Any problems with reconciliating medication: 
n  No
n  Yes, description: 
____________________________________________________________________________
____________________________________________________________________________
Notices:
____________________________________________________________________________
____________________________________________________________________________
Medicine 
(number)
Cautions and  
change suggestions: 
Change suggestions 
approved:  
 
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
n  immediately
n  later
n  not at all
Approved with changes 
and/or later :
Rejected with  
arguments: 
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Appendix 2. Instructions
Medication reconciliation and review
1. HOW TO CHOOSE PATIENTS:  
Amongst the patients admitted, those who fulfill the following criteria will be selected:
• over 65 years
• several diseases and/or using at least  5 medicines when admitting
• is capable to communicate with a clinical pharmacist (for example, no  
  problems with language or acute confusion) 
The choice of suitable patients is made by a physician, nurse or clinical pharmacist.  
To avoid overlapping work the choice of patient is announced to a physician and nurses  
caring for the patient or who in other cases would clarify the medication.
2. CODING THE PATIENT:  
The patient chosen will be given a patient code and the code will be documented  
on both a coding list and on each page in the data collection form.  
 for example 1001A (ward 1, patient 001, clinical pharmacist A)
 or 2001B (ward 2, patient 001, clinical pharmacist B)
3. PATIENT BACKGROUND DATA:  
The patient background data will be entered on the first page of the data collection form.  
The medical records and other sources available are used as the source of information.
• The calculator in the Renbase-data base is used for determining the GFR-value. 
• Only essential laboratory values are documented. 
Time taken for collecting and documenting the patient background data and deleting unnecessary medicines 
in the medicine list will be documented in the upper part of page one of the data collecting form. 
4. INTERVIEWING PATIENT: The patient is interviewed using questions on page two of the data  
collecting form and with the help of the medication list in the medical records (Pegasos). The medication  
list used will be attached to the data collecting form. A/the family member or other career can be interviewed 
if necessary. It is meant to take about 20 minutes to interview the patient. Time consumed in interviewing  
the patient will be documented in the upper part of page two in the data collecting form.  
5. MEDICATION RECONCILIATION:  
Current medication will be reconciled with information obtained from the previous point of care, with help  
by interviewing the patient and/or family member, medical records, medication packages the patient possibly 
has with him/her, prescriptions or administration aids.  The medication reconciled will be documented in the 
medication list used when interviewing the patient. Medicines in the medication list will be numbered  
sequentially to enable them to be marked with numbers in a table in the data collecting form (pp. 3-5).  
The medication list will be attached to the data collecting form.
6. MEDICATION REVIEW:  
(table in data collecting form pp. 3–5): 
 1) Indication: It will be established if there is an indication of medication.  
  The purpose is to find out whether the medication is necessary for the patient. 
 2) Starting date of medication: It will be established whether medication use has  started over or under a  
  year ago. Also the starting date of the medication will be documented if it`s available. With this data it  
  is possible to review whether a new symptom could be an adverse drug reaction. New medications  
  started within a year will more likely cause new adverse drug reactions than those started over a  
  year ago.
 3) Regularity of medication use: It will be established whether the physician has meant the medication  
  to be used regularly, as a cure or only if needed. In this part it will be documented if the medicine  
  is a without prescription medicine. 
 4) Medication use: It will be established, based on patient interview data, how a patient really uses a  
  medicine. Is a patient using a medicine or not? If a patient is not using the medicine ordered for them,  
  it will be documented ”should be in use”.  If a patient is using the medicine which should have been  
  stopped, it will be documented ”should not be in use”. If it is not clear, based on the patient interview,  
  how the patient is really using the medicine, it will be documented ”no knowledge of use”. If the  
  medication is paused for example for a hospital stay, it will be documented “paused”.
 5) Recognition of the problem: Possible drug-related problems will be determined using at least  
  SFINX–PHARAO- and Renbase-databases in Terveysportti, Duodecim medicine database and  
  Fimea medicine database for the elderly. 
To determine potential problems the following will be checked: 
• Are all the medicines necessary for the patient? 
• Are there any missing drugs in the medication list which should be  
   in use concerning the diagnosis and care guidelines? 
• Are the medicines suitable for the patient and is the dosage suitable, taking  
   account of age, indication and possible liver or renal impairment? 
• Has the patient medicine duplications? 
• Are there any interactions between medicines?
• Are the dosing times and intervals correct?
• Do symptoms or laboratory values indicate that the medication doesn`t have sufficient effect?
• Could some of the symptoms in the patient have an adverse drug reaction?
 6) Making a change suggestion: The recognition of a drug-related problem could trigger a change  
  suggestion to solve the problem. Change suggestions and other items taken into account will  
  be documented in a table on a data collecting form (page 6). 
Time consumed for reconciling and reviewing medication will be documented on a data  
collecting form page 3. It will not include time consumed for collecting patient background 
data or patient interviewing, which have been documented in earlier pages.
7. DISCUSSION ABOUT CHANGE SUGGESTIONS:  
When the medication reconciliation and review has been carried out, detected items and possible  
medication change suggestions resulting from them will be discussed together with the physician  
responsible and with a nurse, if needed. The physician will approve or reject the change suggestions.  
A decision made by the physician and arguments for rejecting the decision and possible changes for 
approved suggestions will be documented in the data collecting form (p. 6). In addition, it will be  
documented whether the physician approved the changes to be done at once or later. 
It will be documented in the medical records whether the patients` medication has been reconciled and 
reviewed and which notes were made in optimization and which medication changes were made or are 
planned to be done.  If there has been a discussion with the physician responsible about notes and changes 
it will be enough to write a short description. If there has been no time to meet the physician or changes are 
meant to be carried out in the next step of care, a more accurate description will be recorded about notes 
and change suggestions. Therefore the next step of care will get the information about medication changes 
and can implement them when necessary.
